RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation

Riyaz A Kaba; Douglas Cannie; Omar Ahmed

doi:10.5339/gcsp.2014.26

ISSN: 2305-7823
EISSN:

oa RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation
Authors: Riyaz A Kaba^1,2,3,4, Douglas Cannie² and Omar Ahmed¹
View Affiliations Hide Affiliations

Affiliations: ¹ ¹Ashford & St Peter's Hospitals NHS Foundation Trust, Chertsey, UK ² ²Epsom General Hospital NHS Trust, Epsom, UK ³ ³St George's Hospital NHS Trust, London, UK ⁴ ⁴Royal Holloway, University of London, UK
Source: Global Cardiology Science and Practice, Volume 2014, Issue 2, Aug 2014, 26
DOI: https://doi.org/10.5339/gcsp.2014.26
- Received: 01 June 2014
- Accepted: 21 June 2014
- Published online: 01 September 2014

Abstract

Radiofrequency ablation (RFA) for the treatment of paroxysmal Atrial Fibrillation (pAF) has a class 1 indication in patients who have not tolerated or responded to antiarrhythmic medications. Antiarrhythmic medications (AAM) are, however, limited not only by modest efficacy, but also by significant side effects. Discontinuation rates for AAM range from 11-40% in trials. The RAAFT-2 trial evaluates the use of RFA as a first line treatment for pAF compared to optimal pharmacological management (1).

Article metrics loading...

/content/journals/10.5339/gcsp.2014.26

2014-09-01

2024-11-13

Full text loading...

/deliver/fulltext/gcsp/2014/2/gcsp.2014.26.html?itemId=/content/journals/10.5339/gcsp.2014.26&mimeType=html&fmt=ahah

References

Morillo CA, Verma A, Connolly SJ, Kuck KH, Nair GM, Champagne J, Sterns LD, Beresh H, Healey JS, Natale A, RAAFT-2 Investigators . Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA 2014; 311:7:692–700.
[Google Scholar]
Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, Bash D, Schweikert R, Brachmann J, Gunther J, Gutleben K, Pisano E, Potenza D, Fanelli R, Raviele A, Themistoclakis S, Rossillo A, Bonso A, Natale A. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA 2005; 293:21:2634–2640.
[Google Scholar]
Verma A, Champagne J, Sapp J, Essebag V, Novak P, Skanes A, Morillo CA, Khaykin Y, Birnie D. Discerning the incidence of symptomatic and asymptomatic episodes of atrial fibrillation before and after catheter ablation (DISCERN AF): a prospective, multicenter study. JAMA Intern Med. 2013; 173:2:149–156.
[Google Scholar]

/content/journals/10.5339/gcsp.2014.26

Article Type: Research Article

oa RAAFT-2: Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation

Abstract

Most Read This Month